IP Library › Assignment 041913/0211
Patent Assignment
Reel/Frame 041913/0211

Assignment of Assignor's Interest

Recorded: 2017-03-08 Pages: 37
Assignors
BAZDAR-VINOVRSKI, BILJANA
Executed: 2016-12-15
LAHDENRANTA, MARIA JOHANNA
Executed: 2016-11-26
MACBEATH, GAVIN
Executed: 2017-03-05
MOYO, VICTOR
Executed: 2017-01-05
WAINSZELBAUM, MARISA
Executed: 2016-11-16
Assignee
MERRIMACK PHARMACEUTICALS, INC.
ONE KENDALL SQUARE, SUITE B7201, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Properties (3)
Methods of Treating Cancer by Administering a Bispecific Antibody Antagonist of Igf-Ir and ERBB3 and a Combination of Anti-Egfr Antibodies
Application: 62/244,981 →
Methods of Treating Cancer by Administering a Bispecific Antibody Antagonist of Igf-Ir and ERBB3 and a Combination of Anti-Egfr Antibodies
Application: 62/337,012 →
Methods of Treating Cancer by Administering a Bispecific Antibody Antagonist of Igf-Ir and ERBB3 and a Combination of Anti-Egfr Antibodies
Application: 62/343,969 →
Related Assignments (2)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest Dec 28, 2015
From: MERRIMACK PHARMACEUTICALS, INC.
To: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 037394/0285 →
Release of Security Interest Apr 14, 2017
From: U.S. BANK NATIONAL ASSOCIATION
To: MERRIMACK PHARMACEUTICALS, INC.
Reel/Frame 042254/0349 →